Early research (Phase 1)Study completedNCT00000669
What this trial is testing
A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25